Professional Summary
Professional Overview
Carlos M Hortelano is the Chief Scientific Officer at Linical, a leading Contract Research Organization (CRO) based in Madrid, Spain. With over 25 years of extensive experience in the pharmaceutical and life sciences industry, he has established himself as a respected expert in the field of clinical research and medical affairs.
Experience Summary
Current Role
As the Chief Scientific Officer at Linical, Carlos is responsible for overseeing the company's scientific and medical strategy, ensuring the highest standards of quality and innovation in the delivery of clinical research services. He leads a team of experienced scientists and medical professionals, driving the development and implementation of cutting-edge research methodologies and data analysis techniques. Under his leadership, Linical has strengthened its reputation as a trusted partner for pharmaceutical and biotechnology companies, contributing to the successful execution of numerous clinical trials and regulatory submissions.
Career Progression
Throughout his distinguished career, Carlos has held various senior-level positions across the pharmaceutical industry, including roles as Senior Medical Director Europe at Linical, Medical Director at Nuvisan Pharma Services Group, and Medical Writing Director at MDS Pharma Services. He has consistently demonstrated his ability to drive strategic initiatives, improve operational efficiency, and foster collaborative partnerships with clients and industry stakeholders.
Carlos has a proven track record of leading multi-disciplinary teams, spearheading innovative research projects, and contributing to the advancement of scientific knowledge. His expertise spans a wide range of therapeutic areas, including oncology, immunology, and cardiovascular disease, and he has been instrumental in the successful development and commercialization of several pharmaceutical products.
Academic Background
Carlos holds a Ph.D. in Molecular Biology from the Spanish National School of Health, where he also served as a Professor, leveraging his extensive research experience to educate the next generation of healthcare professionals. His academic achievements and strong scientific background have been instrumental in shaping his career trajectory and enabling him to drive research excellence in the pharmaceutical industry.
Areas of Expertise
- Clinical trial design and management
- Regulatory affairs and submissions
- Medical writing and publications
- Data analysis and interpretation
- Translational research and biomarker development
- Scientific strategy and innovation
- Team leadership and collaboration
Professional Impact
Under Carlos' leadership, Linical has consistently delivered high-quality clinical research services, contributing to the successful development and regulatory approval of numerous pharmaceutical products. He has been recognized for his exceptional contributions to the industry, having served on various scientific advisory boards and presented at prestigious international conferences.
Conclusion
With his vast experience, strong scientific acumen, and proven track record of driving innovation, Carlos M Hortelano is a valuable asset to Linical and the pharmaceutical industry as a whole. As Chief Scientific Officer, he continues to push the boundaries of clinical research, leveraging his expertise to deliver tangible results and contribute to the advancement of medical science.
